Abstract

BackgroundJNJ-40346527, an investigational agent, is a selective inhibitor of the colony stimulating factor-1 receptor (CSF-1R) kinase and acts to inhibit macrophage survival, proliferation and differentiation. Based on current understanding of...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB0412 Clinical Meaningfulness of Radiographic Joint Damage on Physical Function, Employability and Work Productivity in Patients with Rheumatoid Arthritis: Results from the Intravenous Golimumab Study, Go-Further
L Kim ... D Baker
Annals of the Rheumatic Diseases | VOL. 74
L Kim, et. al.L Kim ... D Baker
01 Jun 2015
THU0130 Improvement in measures of depressed mood and anhedonia in two randomized, placebo-controlled phase iii studies of sirukumab, a human anti-interleukin-6 antibody, in patients with rheumatoid arthritis
Gm Wittenberg ... M Curran
Annals of the Rheumatic Diseases | VOL. 76
Gm Wittenberg, et. al.Gm Wittenberg ... M Curran
01 Jun 2017
THU0156 Impact of Golimumab on Physical Function and Employability of Patients with Rheumatoid Arthritis: 5-Year Data from 3 Phase III Clinical Trials
R Fleischmann ... J Smolen
Annals of the Rheumatic Diseases | VOL. 73
R Fleischmann, et. al.R Fleischmann ... J Smolen
01 Jun 2014
THU0091 A Comparison of EQ5D Index from the UK, US, and Japan Preference Weights Model, and Mapping Algorithm from Clinical Outcomes in Patients with Rheumatoid Arthritis: Results of from Simponi Aria Study
C.O Bingham ... L Kim
Annals of the Rheumatic Diseases | VOL. 74
C.O Bingham, et. al.C.O Bingham ... L Kim
01 Jun 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers